181 related articles for article (PubMed ID: 27216370)
1. Fucoidan improves bioactivity and vasculogenic potential of mesenchymal stem cells in murine hind limb ischemia associated with chronic kidney disease.
Lee JH; Ryu JM; Han YS; Zia MF; Kwon HY; Noh H; Han HJ; Lee SH
J Mol Cell Cardiol; 2016 Aug; 97():169-79. PubMed ID: 27216370
[TBL] [Abstract][Full Text] [Related]
2. Fucoidan protects mesenchymal stem cells against oxidative stress and enhances vascular regeneration in a murine hindlimb ischemia model.
Han YS; Lee JH; Jung JS; Noh H; Baek MJ; Ryu JM; Yoon YM; Han HJ; Lee SH
Int J Cardiol; 2015 Nov; 198():187-95. PubMed ID: 26163916
[TBL] [Abstract][Full Text] [Related]
3. Fucoidan Rescues p-Cresol-Induced Cellular Senescence in Mesenchymal Stem Cells via FAK-Akt-TWIST Axis.
Lee JH; Yun CW; Hur J; Lee SH
Mar Drugs; 2018 Apr; 16(4):. PubMed ID: 29642406
[TBL] [Abstract][Full Text] [Related]
4. The sulfated polysaccharide fucoidan rescues senescence of endothelial colony-forming cells for ischemic repair.
Lee JH; Lee SH; Choi SH; Asahara T; Kwon SM
Stem Cells; 2015 Jun; 33(6):1939-51. PubMed ID: 25693733
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.
Kwon YW; Heo SC; Jeong GO; Yoon JW; Mo WM; Lee MJ; Jang IH; Kwon SM; Lee JS; Kim JH
Biochim Biophys Acta; 2013 Dec; 1832(12):2136-44. PubMed ID: 23959047
[TBL] [Abstract][Full Text] [Related]
6. Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2-Smad 1/5/8 signaling in human mesenchymal stem cells.
Kim BS; Kang HJ; Park JY; Lee J
Exp Mol Med; 2015 Jan; 47(1):e128. PubMed ID: 25572360
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced expression of cellular prion protein improves the therapeutic potential of mesenchymal stem cells.
Han YS; Lee JH; Yoon YM; Yun CW; Noh H; Lee SH
Cell Death Dis; 2016 Oct; 7(10):e2395. PubMed ID: 27711081
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Gremlin1 in Mesenchymal Stem Cells Improves Hindlimb Ischemia in Mice by Enhancing Cell Survival.
Xiang Q; Hong D; Liao Y; Cao Y; Liu M; Pang J; Zhou J; Wang G; Yang R; Wang M; Xiang AP
J Cell Physiol; 2017 May; 232(5):996-1007. PubMed ID: 27579673
[TBL] [Abstract][Full Text] [Related]
9. Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells.
Ma Q; Xia X; Tao Q; Lu K; Shen J; Xu Q; Hu X; Tang Y; Block NL; Webster KA; Schally AV; Wang J; Yu H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):663-672. PubMed ID: 26868211
[TBL] [Abstract][Full Text] [Related]
10. IL-8 enhances the angiogenic potential of human bone marrow mesenchymal stem cells by increasing vascular endothelial growth factor.
Hou Y; Ryu CH; Jun JA; Kim SM; Jeong CH; Jeun SS
Cell Biol Int; 2014 Sep; 38(9):1050-9. PubMed ID: 24797366
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia.
Madonna R; Taylor DA; Geng YJ; De Caterina R; Shelat H; Perin EC; Willerson JT
Circ Res; 2013 Sep; 113(7):902-14. PubMed ID: 23780385
[TBL] [Abstract][Full Text] [Related]
12. Co-injection of mesenchymal stem cells with endothelial progenitor cells accelerates muscle recovery in hind limb ischemia through an endoglin-dependent mechanism.
Rossi E; Smadja D; Goyard C; Cras A; Dizier B; Bacha N; Lokajczyk A; Guerin CL; Gendron N; Planquette B; Mignon V; Bernabéu C; Sanchez O; Smadja DM
Thromb Haemost; 2017 Oct; 117(10):1908-1918. PubMed ID: 28771278
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic characteristics of human stromal vascular fraction in ischemic hindlimb.
Jin E; Chae DS; Son M; Kim SW
Int J Cardiol; 2017 May; 234():38-47. PubMed ID: 28258850
[TBL] [Abstract][Full Text] [Related]
14. Angio-Vasculogenic Properties of Endothelial-Induced Mesenchymal Stem Cells Derived From Human Adipose Tissue.
Guo LZ; Kim TH; Han S; Kim SW
Circ J; 2016; 80(4):998-1007. PubMed ID: 26853554
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic Preconditioning Promotes the Bioactivities of Mesenchymal Stem Cells via the HIF-1α-GRP78-Akt Axis.
Lee JH; Yoon YM; Lee SH
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635661
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of biological effects of mesenchymal stem cells in ischemic conditions by melatonin via upregulation of cellular prion protein expression.
Lee JH; Han YS; Lee SH
J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 28095625
[TBL] [Abstract][Full Text] [Related]
18. C-Met-Activated Mesenchymal Stem Cells Rescue Ischemic Damage via Interaction with Cellular Prion Protein.
Han YS; Yun SP; Lee JH; Kwon SH; Kim S; Hur J; Lee SH
Cell Physiol Biochem; 2018; 46(5):1835-1848. PubMed ID: 29705776
[TBL] [Abstract][Full Text] [Related]
19. Combined Treatment with Systemic and Local Delivery of Substance P Coupled with Self-Assembled Peptides for a Hind Limb Ischemia Model.
Kim JE; Jung KM; Kim SH; Jung Y
Tissue Eng Part A; 2016 Mar; 22(5-6):545-55. PubMed ID: 26873410
[TBL] [Abstract][Full Text] [Related]
20. Effect of brain-derived neurotrophic factor on mesenchymal stem cell-seeded electrospinning biomaterial for treating ischemic diabetic ulcers via milieu-dependent differentiation mechanism.
He S; Shen L; Wu Y; Li L; Chen W; Hou C; Yang M; Zeng W; Zhu C
Tissue Eng Part A; 2015 Mar; 21(5-6):928-38. PubMed ID: 25316594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
